Respiratory syncytial virus prevention and therapy: past, present, and future - PubMed

Affiliations

• PMID: 21438168
• DOI: 10.1002/ppul.21377

Review

Respiratory syncytial virus prevention and therapy: past, present, and future

Melvin Wright et al. Pediatr Pulmonol. 2011 Apr.

Abstract

Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and young children worldwide. More than 50 years after its discovery, and despite relentless attempts to identify pharmacological therapies to improve the clinical course and outcomes of this disease, the most effective therapy remains supportive care. Although the quest for a safe and effective vaccine remains unsuccessful, pediatricians practicing during the past decade have been able to protect at least the more vulnerable patients with safe and effective passive prophylaxis. This review summarizes the history, microbiology, epidemiology, pathophysiology, and clinical manifestations of this infection in order to provide the reader with the background information necessary to fully appreciate the many challenges presented by the clinical management of young children with bronchiolitis. The last part of this article attempts an evidence-based review of the pharmacologic strategies currently available and those being evaluated, intentionally omitting highly experimental approaches not yet tested in clinical trials and, therefore, not likely to become available in the foreseeable future.

Similar articles

• Preventive and therapeutic strategies for respiratory syncytial virus infection.

  Vujovic O, Mills J. Vujovic O, et al. Curr Opin Pharmacol. 2001 Oct;1(5):497-503. doi: 10.1016/s1471-4892(01)00087-x. Curr Opin Pharmacol. 2001. PMID: 11764776 Review.

• Respiratory syncytial virus: prospects for new and emerging therapeutics.

  Jorquera PA, Tripp RA. Jorquera PA, et al. Expert Rev Respir Med. 2017 Aug;11(8):609-615. doi: 10.1080/17476348.2017.1338567. Epub 2017 Jun 14. Expert Rev Respir Med. 2017. PMID: 28574729 Review.

• Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.

  Empey KM, Peebles RS Jr, Kolls JK. Empey KM, et al. Clin Infect Dis. 2010 May 1;50(9):1258-67. doi: 10.1086/651603. Clin Infect Dis. 2010. PMID: 20235830 Free PMC article. Review.

• Respiratory syncytial virus bronchiolitis: prevention and treatment.

  Faber TE, Kimpen JL, Bont LJ. Faber TE, et al. Expert Opin Pharmacother. 2008 Oct;9(14):2451-8. doi: 10.1517/14656566.9.14.2451. Expert Opin Pharmacother. 2008. PMID: 18778183 Review.

• Respiratory syncytial virus infections: characteristics and treatment.

  Chidgey SM, Broadley KJ. Chidgey SM, et al. J Pharm Pharmacol. 2005 Nov;57(11):1371-81. doi: 10.1211/jpp.57.11.0001. J Pharm Pharmacol. 2005. PMID: 16259768 Review.

Cited by

• Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey.

  Jung JW. Jung JW. Korean J Pediatr. 2011 May;54(5):192-6. doi: 10.3345/kjp.2011.54.5.192. Epub 2011 May 31. Korean J Pediatr. 2011. PMID: 21829409 Free PMC article.

• Approved Antiviral Drugs over the Past 50 Years.

  De Clercq E, Li G. De Clercq E, et al. Clin Microbiol Rev. 2016 Jul;29(3):695-747. doi: 10.1128/CMR.00102-15. Clin Microbiol Rev. 2016. PMID: 27281742 Free PMC article. Review.

• Respiratory syncytial virus infection as a precipitant of thyroid storm in a previously undiagnosed case of graves' disease in a prepubertal girl.

  Aslan IR, Baca EA, Charlton RW, Rosenthal SM. Aslan IR, et al. Int J Pediatr Endocrinol. 2011;2011(1):138903. doi: 10.1155/2011/138903. Epub 2011 Mar 22. Int J Pediatr Endocrinol. 2011. PMID: 21603250 Free PMC article.

• A multiplex recombinase polymerase amplification assay combined with CRISPR/Cas12a for the detection of respiratory syncytial virus and respiratory adenovirus.

  Hongdan G, Yao D, Qiang C, Meng H, Xiaorong L, Zhihao X, Dongli M. Hongdan G, et al. J Int Med Res. 2024 Jan;52(1):3000605231223083. doi: 10.1177/03000605231223083. J Int Med Res. 2024. PMID: 38230675 Free PMC article.

• Environmental factors affecting the transmission of respiratory viruses.

  Pica N, Bouvier NM. Pica N, et al. Curr Opin Virol. 2012 Feb;2(1):90-5. doi: 10.1016/j.coviro.2011.12.003. Epub 2012 Jan 4. Curr Opin Virol. 2012. PMID: 22440971 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal